Features of the nutrition for the autism spectrum disorders

Authors

DOI:

https://doi.org/10.18370/2309-4117.2019.49.73-77

Keywords:

autism spectrum disorders, nutrition, folates, folic acid, omega-3 polyunsaturated fatty acids

Abstract

In most countries of the world there is a continuous increase in the number of patients with autism spectrum disorders (ASD). ASD is defined as a heterogeneous group of disorders of the nervous system development, which have a diverse etiology, but characterized by common symptoms associated with impaired social interaction, communication and behavior, and is the result of the interaction of genetic and epigenetic factors.

Diet therapy of autism is one of the safest methods to prevent the progression of disease and improve the functional state of the central nervous system and other organs. It should be recommended that industrial products containing unwanted xenobiotics, aluminum, soy, estrogens, pesticides, sweeteners, trans fatty acids be excluded from use. The nutrition of a patient with ASD should provide the body with the necessary energy, plastic and regulatory factors, take into account age and nutritional status.

Fatty nutrition of a pregnant and lactating woman is important. Lipids are the main structural components of the brain. The content of fatty acids in brain is much higher than in other organs. Brain is especially rich in omega-3 polyunsaturated fatty acids. The content and ratio of individual classes of lipids significantly change during the development and differentiation of brain. These processes occur most intensively in early postnatal ontogenesis, therefore it is important to provide the pregnant woman with omega-3 polyunsaturated fatty acids. A positive effect was found in ASD diets with the exception of gluten and casein.

It is important for the prevention of ASD to provide a woman with folic acid before and during pregnancy (up to 12 weeks of pregnancy), which can prevent changes in neuro-behavioral and emotional skills. An adequate dose and form of folic acid is important. A large dose of it is as dangerous as its deficiency. An excess of folic acid leads to a decrease in the content of endogenous folates. Preference should be given to the active form of folate 5-methyltetrahydrofolate, since it does not cause a blockage of folate metabolism

Author Biography

Г. А. Анохіна, P.L. Shupik National Medical Academy of Postgraduate Education, Kyiv

MD, professor of the Department of Gastroenterology, Dietetics and Endoscopy

References

Grechanina, E.Y., Husar, V.A. “The prevalence of C677T MTHFR and A66G MTRR polymorphisms of folate cycle system genes in the population of Eastern Ukraine.” In: Actual problems of obstetrics and gynecology, clinical immunology and medical genetics, collection of scientific papers. Kyiv- Lugansk (2010 ): 91–7.

Gulyaev, A.E. “Multivitamins for pregnant women: a review of recommendations based on evidence-based medicine.” Gynecology, Obstetrics and Perinatology 13.5 (2014): 53–62.

Grodnitskaya, E.E. “Folate and homocysteine metabolism disorders in the development of pregnancy complications.” Russian Bulletin of Obstetrician-Gynecologist 4 (2010): 20–4.

Kodentsova, V.M., Vrzhesinskaya, O.A. “Vitamins in the nutrition of pregnant and lactating women.” Questions of Gynecology, Obstetrics and Perinatology 12.3 (2013): 38–50.

Mozgovaya, E.V., Prokopenko, V.M., Oparina, T.I., Novikova, T.D. “Evaluation of the clinical effectiveness of the vitamin-mineral complex for prevention of pregnancy complications.” Obstetrics and Gynecology 4 (2011): 89–94.

Weiner, A.C., Zhechev, D.A., Shirshova, A.N., et al. “System of folate metabolism and congenital malformations: the effect of the maternal genotype.” Mother and Child in Kuzbass 4.51 (2012): 7–12.

Fofanova, I.Y., Prilepskaya, V.N. “Once again about the problem of folate insufficiency.” Medical Council 9 (2014): 80–3.

Abe, I., Shirato, K., Hashizume, Y. “Folate-deficiency induced cell-specific changes in the distribution of lymphocytes and granulocytes in rats.” Environ Health Prev Med 18.1 (2013): 78–84.

Adams, J.B., Audhya, T., McDonough-Means, S., et al. “Effect of a vitamin/mineral supplement on children and adults with autism.” BMC Pediatr 11 (2011). 10. Adams, J.B., Audhya, T., McDonough-Means, S., et al. “Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity.” Nutr Metab (Lond) 8.1 (2011).

Agopian, A.J., Tinker, S.C., Lupo, P.J., et al. “National Birth Defects Prevention Study. Proportion of neural tube defects attributable to known risk factors. Birth Defects Research Part A.” Clinical and Molecular Teratology 97 (2013): 42–6.

Bailey, R.L., West, K.P. Jr., Black, R.E. “The epidemiology of global micronutrient deficiencies.” Ann Nutr Metab 66.2 (2015): 22–33.

Bergen, N.E., Jaddoe, V.W., Timmermans, S., et al. “Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: the Generation R Study.” BJOG 13 (2012): 739–51.

Biamino, E., Di Gregorio, E., Belligni, E.F. “A novel 3q29 deletion associated with autism, intellectual disability, psychiatric disorders, and obesity.” Am J Med Genet Part B: Neuropsychiatr Genet (2015).

Borges, M.C., Hartwig, F.P., Oliveira, I.O., Horta, B.L. “Is there a causal role for homocysteine concentration in blood pressure? A Mendelian randomization study.” Am J Clin Nutr 103.1 (2016): 39–49.

Buie, T. “The relationship of autism and gluten.” Clin Ther 35.5 (2013): 578–83. DOI: 10.1016/j.clinthera.2013.04.011ER

Dimitroulas, T., Sandoo, A., Hodson, J., et al. “Associations between asymmetric dimethylarginine, homocysteine, and the methy-lenetetrahydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) in rheumatoid arthritis.” Scand J Rheumatol (2015).

Dosman, C., Adams, D., Wudel, B., et al. “Complementary, holistic, and integrative medicine: autism spectrum disorder and gluten- and casein-free diet.” Pediatr Rev 34.10 (2013): e36–41. DOI: 10.1542/pir.34-10-e36

Blencowe, H., Cousens, S., Modell, B., Lawn, J. “Folic acid to reduce neonatal mortality from neural tube disorders.” Int J Epidemiol 39 (2010): 110–21.

Gomes, S., Lopes, C., Pinto, E. “Folate and folic acid in the periconceptional period: recommendations from official health organizations in thirty-six countries worldwide and WHO.” Public Health Nutr (2015): 1–14.

Hodgetts, V.A., Morris, R.K., Francis, A., et al. “Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small-for-gestational age neonates: a population study, systematic review and meta-analysis.” BJOG 122.4 (2015): 478–90.

Fekete, K., Berti, C., Trovato, M., et al. “Effect of folate intake on health outcomes in pregnancy: a systematic review and meta-analysis on birth weight, placental weight and length of gestation.” Nutrition J 13 (2012): 75.

Flores, A.L., Vellozzi, C., Valencia, D., Sniezek, J. “Global burden of neural tube defects, risk factors, and prevention.” Ind J Commun Health 26.1 (2014): 3–5.

Friberg, A.K., Jorgensen, F.S. “Periconceptional folic acid prophylaxis and neural tube defects.” Ugeskr Laeger 177.11 (2015): 10140533.12.

Hanks, J. “The association between MTHFR 677C>T genotype and folate status and genomic and gene-specific DNA methylation in the colon of individuals without colorectal neoplasia.” Am J Clin Nutr 98.6 (2013): 1564–74.

Hart, J., Bock, K.A., Cartaxo, A., et al. “Roundtable Discussion: The impact of GI and nutritional issues on autism.” Altern Complement Ther 21.2 (2015): 84–9. DOI: 10.1089/act.2015.21207

Harris, C., Card, B. “A pilot study to evaluate nutritional influences on gastrointestinal symptoms and behavior patterns in children with autism spectrum disorder.” Complement Ther Med 20.6 (2012): 437–40. DOI: 10.1016/j.ctim.2012.08.004

Herbert, M.R., Buckley, J.A. “Autism and dietary therapy: case report and review of the literature.” J Child Neurol 28.8 (2013): 975–82. DOI: 10.1177/0883073813488668

Höfer, J., Hoffmann, F., Bachmann, C. “Use of complementary and alternative medicine in children and adolescents with autism spectrum disorder: a systematic review.” Pediatrics (2016). DOI: 10.1177/136 2361316646559pmid:27231337

Hurwitz, S. “The gluten-free, casein-free diet and autism: limited return on family investment.” J Early Interv 35.1 (2013): 3–19. DOI: 10.1177/1053815113484807

Hyman, S.L., Stewart, P.A., Smith, T.H., et al. “The gluten free and casein free (GFCF) diet: a double blind, placebo controlled challenge study.” Presented at: the International Meeting for Autism Research; May 22, 2010; Philadelphia, PA. Available from: [https://imfar.confex.com/imfar/2010/webprogram/Paper6183.html].

Johnson, C.R., Handen, B.L., Zimmer, M., et al. “Effects of gluten free/casein free diet in young children with autism:

Kang, V., Wagner, G.C., Ming, X. “Gastrointestinal dysfunction in children with autism spectrum disorders.” Autism Res 7.4 (2014): 501–6. DOI: 10.1002/aur.1386

Lu, W.P., Lu, M.S., Li, Z.H., Zhang, C.X. “Effects of multimicronutrient supplementation during pregnancy on postnatal growth of children under 5 years of age: a meta-analysis of randomized controlled trials.” PLoS One (2014).

Liu, X., Liu, J., Xiong, X., et al. “Correlation between nutrition and symptoms: nutritional survey of children with autism spectrum disorder in Chongqing, China.” Nutrients 8.5 (2016): E294.

Mari-Bauset, S., Zazpe, I., Mari-Sanchis, A., et al. “Evidence of the gluten-free and casein-free diet in autism spectrum disorders: a systematic review.” J Child Neurol 29.12 (2014): 1718–27. DOI: 10.1177/0883073814531330

Morales de Machin, A., Mendez, K., Solis, E., et al. “C677T polymorphism of the methylentetrahydrofolate reductase gene in mothers of children affected with neural tube defects.” Invest Clin 56.3 (2015): 284–95.

Mulloy, A., Lang, R., O’Reilly, M., et al. “Gluten-free and casein-free diets in the treatment of autism spectrum disorders: a systematic review.” Res Autism Spectr Disord 4.3 (2010): 328–39. DOI: 10.1016/j.rasd.2009.10.008

Mulloy, A., Lang, R., O’Reilly, M., et al. “Addendum to gluten-free and casein-free diets in treatment of autism spectrum disorders: A systematic review.” Res Autism Spectr Disord 5.1 (2011): 86–8. DOI: 10.1016/j.rasd.2010.07.004

Peng, Q., Lao, X., Huang, X., et al. “The MTHFR C677T polymorphism contributes to increased risk of Alzheimer's disease: evidence based on 40 case-control studies.” Neurosci Lett 586 (2015): 36–42.

Pennesi, C.M., Klein, L.C. “Effectiveness of the gluten-free, casein-free diet for children diagnosed with autism spectrum disorder: Based on parental report.” Nutr Neurosci 15.2 (2012): 85–91. DOI: 10.1179/1476830512Y.0000000003

Pedersen, L., Parlar, S., Kvist, K., et al. “Data mining the ScanBrit study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders: behavioural and psychometric measures of dietary response.” Nutr Neurosci 17.5 (2014): 207–13. DOI: 10.1179/1476830513Y.0000000082

Perrin, J.M., Coury, D.L., Hyman, S.L., et al. “Complementary and alternative medicine use in a large pediatric autism sample.” Pediatrics 130 Suppl. 2 (2012): S77–S82.

Pu, D., Shen, Y., Wu, J. “Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a metaanalysis.” Autism Res 6.5 (2013): 384–92.

Qi, X., Sun, X., Xu, J., et al. “Associations between methylenetet-rahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population.” Tumour Biol 35.3 (2014): 1757–62.

Srinivasan, P. “A review of dietary interventions in autism.” Ann Clin Psychiatry 21.4 (2009): 237–47.

Owen-Smith, A.A., Bent, S., Lynch, F.L., et al. “Prevalence and predictors of complementary and alternative medicine use in a large insured sample of children with autism spectrum disorders.” Res Autism Spectr Disord 17 (2015): 40–51.

Whiteley, P., Shattock, P., Knivsberg, A.M., et al. “Gluten- and casein-free dietary intervention for autism spectrum conditions.” Front Hum Neurosci 6 (2013): 344. DOI: 10.3389/fnhum.2012.00344

Whiteley, P., Haracopos, D., Knivsberg, A.M., et al. “The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders.” Nutr Neurosci 13.2 (2010): 87–100.

Winburn, E., Charlton, J., McConachie, H., et al. “Parents’ and child health professionals’ attitudes towards dietary interventions for children with autism spectrum disorders.” J Autism Dev Disord 44.4 (2014): 747–57.

van De Sande, M.M.H., van Buul, V.J., Brouns, F.J.P.H. “Autism and nutrition: the role of the gut–brain axis.” Nutr Res Rev 27.2 (2014): 199–214. DOI: 10.1017/S0954422414000110

Zhang, J., Mayton, M.R., Wheeler, J.J. “Effectiveness of gluten-free and casein-free diets for individuals with autism spectrum disorders: an evidence-based research synthesis.” Educ Train Autism Dev Disabil 48.2 (2013): 276–87.

Tatarchuk, T., Zakharenko, N., Bachynska, I., Kosei, N. “On the issue of autoimmune ovary damage during puberty.” Georgian medical news 279 (2018): 49–56.

Published

2019-12-06

Issue

Section

Interdisciplinary problems